Literature DB >> 17939050

Barrett's columnar-lined oesophagus: demographic and lifestyle associations and adenocarcinoma risk.

P A C Gatenby1, C P J Caygill, J R Ramus, A Charlett, A Watson.   

Abstract

OBJECTIVES: Lifestyle and demographic risk factors for the development of oesophageal adenocarcinoma developing from columnar-lined oesophagus are not well defined.
METHODS: Demographic and lifestyle factors, endoscopy and histology reports were extracted from 1,761 subjects from seven UK centres. The associations of columnar-lined oesophagus with demographic and lifestyle factors and the development of adenocarcinoma were examined.
RESULTS: 5.5% of patients had prevalent adenocarcinoma (more common in males, older patients, patients diagnosed earlier in the cohort and current or recent smokers). Adenocarcinoma incidence was 23 patients in 3,912 years or 0.59% per annum. Only increased age at diagnosis correlated with an increased risk of incident adenocarcinoma. There was no association with obesity or alcohol history.
CONCLUSIONS: Oesophageal adenocarcinoma occurs more commonly in older patients and is more frequent in males than females. Once columnar-lined oesophagus had been diagnosed, there were no other demographic or lifestyle factors which were predictive of the development of incident adenocarcinoma in this cohort.

Entities:  

Mesh:

Year:  2007        PMID: 17939050     DOI: 10.1007/s10620-007-0023-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  A cost analysis of outpatient care for patients with Barrett's esophagus in a managed care setting.

Authors:  M A Eloubeidi; R K Homan; M D Martz; K E Theobald; D Provenzale
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

Review 2.  Global cancer statistics in the year 2000.

Authors:  D M Parkin
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

3.  Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.

Authors:  C Ell; A May; L Gossner; O Pech; E Günter; G Mayer; R Henrich; M Vieth; H Müller; G Seitz; M Stolte
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

4.  Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.

Authors:  D Provenzale; C Schmitt; J B Wong
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

5.  Cost-effectiveness of screening a population with chronic gastroesophageal reflux.

Authors:  Paul J Nietert; Marc D Silverstein; Mahesh S Mokhashi; Christopher Y Kim; Tammy F Glenn; Vicki A Marsi; Robert H Hawes; Michael B Wallace
Journal:  Gastrointest Endosc       Date:  2003-03       Impact factor: 9.427

6.  Oesophageal cancer in France and Switzerland: recent time trends.

Authors:  A J Tuyns
Journal:  Eur J Cancer Prev       Date:  1992-04       Impact factor: 2.497

7.  Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer.

Authors:  J M Streitz; F H Ellis; R L Tilden; R V Erickson
Journal:  Am J Gastroenterol       Date:  1998-06       Impact factor: 10.864

  7 in total
  9 in total

1.  Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

Authors:  Shivaram Bhat; Helen G Coleman; Fouad Yousef; Brian T Johnston; Damian T McManus; Anna T Gavin; Liam J Murray
Journal:  J Natl Cancer Inst       Date:  2011-06-16       Impact factor: 13.506

Review 2.  Barrett's oesophagus: Evidence from the current meta-analyses.

Authors:  Piers Gatenby; Yuen Soon
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

3.  Predictors of dysplastic and neoplastic progression of Barrett’s esophagus

Authors:  Saleh Alnasser; Raman Agnihotram; Myriam Martel; Serge Mayrand; Eduardo Franco; Lorenzo Ferri
Journal:  Can J Surg       Date:  2019-04-01       Impact factor: 2.089

4.  Barrett's esophagus: where do we stand?

Authors:  Majid A Al Madi
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

5.  Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.

Authors:  Piers Gatenby; Christine Caygill; Christine Wall; Santanu Bhatacharjee; James Ramus; Anthony Watson; Marc Winslet
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

6.  Alcohol consumption and the neoplastic progression in Barrett's esophagus: a systematic review and meta-analysis.

Authors:  Zhifeng Lou; Haibo Xing; Da Li
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

7.  Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillance.

Authors:  Piers Gatenby; Santanu Bhattacharjee; Christine Wall; Christine Caygill; Anthony Watson
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

8.  An Urban Center Experience Exploring Barriers to Adherence to Endoscopic Surveillance for Non-Dysplastic Barrett's Esophagus.

Authors:  Mahmoud Isseh; Laurel Mueller; Hussna Abunafeesa; Zaid Imam; Dania Shakaroun; Mouhanna Abu Ghanimeh; Nazih Isseh; Joseph Miller; Syed-Mohammed Jafri; Adrienne Lenhart
Journal:  Cureus       Date:  2021-01-31

9.  Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men.

Authors:  Tomoyuki Akiyama; Masahiko Inamori; Hiroshi Iida; Hironori Mawatari; Hiroki Endo; Kunihiro Hosono; Kyoko Yoneda; Koji Fujita; Masato Yoneda; Hirokazu Takahashi; Ayumu Goto; Yasunobu Abe; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2008-12-11       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.